Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $61,332.00 |
|---|---|
| Enterprise Value | $3.24 Million |
| Earnings per Share | $-2.09 |
| Beta | -0.06 |
| Outstanding Shares | 2,190,417 |
| P/E Ratio | -0.01 |
|---|---|
| PEG | -0.04 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.25 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.98 |
| Debt to Equity | -0.44 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of ex...